Holen Sie sich die Stockscreener-App
58.90
0.93%
0.54
Vorhandelsmarkt:
58.67
-0.23
-0.39%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$58.36
Offen:
$58.68
24-Stunden-Volumen:
2.90M
Relative Volume:
1.17
Marktkapitalisierung:
$24.71B
Einnahmen:
$4.80B
Nettoeinkommen (Verlust:
$-66.50M
KGV:
-346.47
EPS:
-0.17
Netto-Cashflow:
$558.47M
1W Leistung:
+2.63%
1M Leistung:
-2.19%
6M Leistung:
+10.24%
1J Leistung:
+22.66%
1-Tages-Spanne:
$58.35
$58.99
1-Wochen-Bereich:
$56.97
$59.49
52-Wochen-Spanne:
$41.45
$67.61
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Branche
Telefon
(312) 660-3800
Adresse
353 N. CLARK STREET, CHICAGO, IL
Vergleichen Sie VTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
58.90 | 24.71B | 4.80B | -66.50M | 558.47M | -0.17 |
|
WELL
Welltower Inc
|
129.34 | 80.54B | 7.35B | 915.62M | 2.01B | 1.52 |
|
DOC
Healthpeak Properties Inc
|
20.78 | 14.53B | 2.53B | 309.54M | 953.27M | 0.47 |
|
OHI
Omega Healthcare Investors Inc
|
37.36 | 10.09B | 1.01B | 347.99M | 685.44M | 1.36 |
|
HR
Healthcare Realty Trust Inc
|
16.48 | 5.84B | 1.29B | -588.17M | 230.02M | -1.58 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
What to Expect From Ventas' Next Quarterly Earnings Report - Nasdaq
Merit Financial Group LLC Buys 5,115 Shares of Ventas, Inc. (NYSE:VTR) - MarketBeat
What To Expect From Ventas' Next Quarterly Earnings Report - Barchart
Ventas trades higher after Baird's upgrade on improved fundamentals - MSN
Ritholtz Wealth Management Increases Stock Holdings in Ventas, Inc. (NYSE:VTR) - MarketBeat
Baird bullish on Ventas stock as leverage reduction and capital access improve outlook - MSN
Foresight Group Ltd Liability Partnership Purchases 11,769 Shares of Ventas, Inc. (NYSE:VTR) - MarketBeat
Baird R W Upgrades Ventas (NYSE:VTR) to Strong-Buy - MarketBeat
Avanza Fonder AB Buys Shares of 42,430 Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas trades higher after Baird's upgrade on improved fundamentals (VTR:NYSE) - Seeking Alpha
This American Airlines Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - Benzinga
Ventas (NYSE:VTR) Rating Increased to Outperform at Robert W. Baird - MarketBeat
LogoVentas Announces Fourth Quarter 2024 Earnings Release Date and Conference Call - Business Wire
USA Financial Formulas Takes Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
Czech National Bank Has $5.36 Million Stake in Ventas, Inc. (NYSE:VTR) - MarketBeat
REITs Look to Reinvestment to Create Value & Drive Growth - Nareit
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas (NYSE:VTR) Cut to Sell at StockNews.com - MarketBeat
10 of the Best REITs to Buy for 2025 | Investing - U.S News & World Report Money
3 Healthcare REITs Offering Healthy Dividend Yields - Inkl
WELL: 3 Healthcare REITs Offering Healthy Dividend Yields - StockNews.com
Pensionfund DSM Netherlands Has $3.99 Million Stake in Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas Inc. stock rises Friday, still underperforms market - MarketWatch
Ventas sees FY 2017 adjusted FFO per share $4.12 to $4.18 - Reuters.com
Ventas Reaches Mutually Beneficial Agreements With Brookdale - MSN
Ventas, Inc. (NYSE:VTR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Ventas Inc. stock underperforms Monday when compared to competitors - MarketWatch
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
CEO Debra Cafaro Leads The Way at Health Care REIT Ventas - Nareit
Ex-Dividend Reminder: Ventas, RLJ Lodging Trust and MFA Financial - Nasdaq
JPMorgan Chase & Co. Has $1.77 Billion Stock Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
Is Ventas Stock Underperforming the Nasdaq? - MSN
Brookdale Senior Living Confirmed its Not Exercising its Right to Renew on Master Lease with Ventas - Yield PRO magazine
Ventas Inc. stock rises Tuesday, still underperforms market - MarketWatch
Ventas shares retain Outperform rating as analyst highlights reduced BKD exposure - Investing.com Canada
8 Best Real Estate Stocks to Buy | Investing - U.S News & World Report Money
Ventas Inc. stock rises Monday, still underperforms market - MarketWatch
Validea Detailed Fundamental AnalysisVTR - Nasdaq
Ventas, Brookdale Senior Living agree on partial lease extension - MSN
Brookdale stock maintains Buy rating as Jefferies highlights cleaner investment story By Investing.com - Investing.com
Ventas (NYSE:VTR) Upgraded by StockNews.com to Hold Rating - MarketBeat
Baird raises Ventas stock target, sees SHOP assets boosting NOI from 2025 onwards - Investing.com India
Here's Why You Should Retain Ventas Stock in Your Portfolio Now - MSN
Ventas (NYSE:VTR) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Ventas (NYSE:VTR) Price Target Raised to $66.00 - MarketBeat
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):